Suchergebnisse - "Burhenne, Jürgen"

PubPharm (15)

1

Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)

enthalten in: International journal of molecular sciences | 2024

von Rigalli, J. | Gagliardi, A. | Diester, K. | +11

2

Simultaneous quantification and pharmacokinetic characterization of doxapram and 2-ketodoxapram in porcine plasma and brain tissue

enthalten in: Pharmaceutics | 31 March 2022

von Kraft, M. | Foerster, K. | Wiedmann, F. | +9

3

Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue

enthalten in: Pharmaceutics | 2022

von Kraft, M. | Foerster, K. | Wiedmann, F. | +9

4

Differential Effect of a Continental Breakfast on Tacrolimus Formulations With Different Release Characteristics

enthalten in: Clinical pharmacology in drug development | 2021

von Huppertz, A. | Bollmann, J. | Behnisch, R. | +5

5

Differential effect of a continental breakfast on tacrolimus formulations with different release characteristics

enthalten in: Clinical pharmacology in drug development | 2021

von Huppertz, A. | Bollmann, J. | Behnisch, R. | +5

6

New Insights Into the Pharmacokinetics of Vancomycin After Oral and Intravenous Administration : An Investigation in Beagle Dogs

enthalten in: Journal of pharmaceutical sciences | 2020

von Sauter, M. | Uhl, P. | Meid, A. | +3

7

New insights into the pharmacokinetics of vancomycin after oral and intravenous administration : an investigation in beagle dogs

enthalten in: Journal of pharmaceutical sciences | 20 March 2020

von Sauter, M. | Uhl, P. | Meid, A. | +3

8

Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers

enthalten in: British journal of clinical pharmacology | 2019

von Brings, A. | Lehmann, M. | Foerster, K. | +4

9

Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers

enthalten in: British journal of clinical pharmacology | 25 March 2019

von Brings, A. | Lehmann, M. | Foerster, K. | +4

10

Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics

enthalten in: British journal of clinical pharmacology | 2017

von Hohmann, N. | Kreuter, R. | Blank, A. | +4